※ 원활한 환경을 위해 엣지 또는 크롬 브라우저에서 시청하시기 바랍니다.

※ If you don't see the videos, please use Google Chrome or Microsoft Edge.

01. Opening Remarks

02. Overview of pharmacovigilance system in Korea

03. Overview of pharmacovigilance system in Korea Q&A

04. Sharing action plans for the regulatory harmonization in pharmacovigilance

05. Sharing action plans for the regulatory harmonization in pharmacovigilance Q&A

06. Pharmacovigilance and medication error reporting system

07. Pharmacovigilance and medication error reporting system Q&A

08. Sharing various economies’ strategies to improve their pharmacovigilance system (Chile)

09. Sharing various economies’ strategies to improve their pharmacovigilance system (Indonesia)

10. Sharing various economies’ strategies to improve their pharmacovigilance system (Philippines)

11. Sharing various economies’ strategies to improve their pharmacovigilance system (Taiwan)

12. Sharing various economies’ strategies to improve their pharmacovigilance system (Thailand)

13. Effective risk communication - PMDA experience
 

14. Effective risk communication - PMDA experience Q&A

15. Quality management of pharmacovigilance - Pharmacovigilance inspection

16. Quality management of pharmacovigilance - Pharmacovigilance inspection Q&A

17. Principles of adverse event assessment - Signal detection

18. Principles of adverse event assessment - Q&A

19. Tools for enhanced pharmacovigilance_ advanced signal detection

20. Tools for enhanced pharmacovigilance_ advanced signal detection Q&A

21. Risk management plan (RMP) - Specific product-related RMP, tools and activities

22. Risk management plan (RMP) - Specific product-related RMP, tools and activities Q&A

23. Wrap up and Closing Remarks